EUVIMEDEUVIMED entdecken
Crossref

Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism

Denise Bruedgam iD, Christian Adolf iD, Holger Schneider iD, Paul Schwarzlmueller, Lisa Mueller, Laura Handgriff, Martin Bidlingmaier iD, Sonja Kunz, Petra Zimmermann, Sinan Deniz, Tracy Ann Williams, Felix Beuschlein iD und 2 weitere

European Journal of Endocrinology · 2023

DOI: 10.1093/ejendo/lvad159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2023. Verfasst von Denise Bruedgam und 13 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik IV, LMU Klinikum, 80336 München, Germany. Hauptthemen laut MEDLINE: Hyperaldosteronism, Adrenocortical Adenoma, Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Else Kröner-Fresenius-Stiftung, German Conn's, Registry‒Else Kröner Hyperaldosteronism Registry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Primary aldosteronism (PA) is the most common surgically curable cause of hypertension. Unilateral aldosterone-producing adenoma can be treated with adrenalectomy. Clinical and biochemical outcomes are assessed 6-12 months after adrenalectomy according to primary aldosteronism surgical outcome (PASO) consensus criteria. Earlier prediction of biochemical remission would be desirable as it could reduce cumbersome follow-up visits. We hypothesized that postoperative adrenocorticotropic hormone (ACTH) stimulated plasma aldosterone concentrations (PAC) measured shortly after adrenalectomy can predict PASO outcomes.

Design

Retrospective cohort study.

Methods

We analyzed 100 patients of the German Conn's registry who underwent adrenalectomy and postoperative ACTH stimulation tests within the first week after adrenalectomy. Six to twelve months after adrenalectomy we assessed clinical and biochemical outcomes according to PASO criteria. Serum cortisol and PAC were measured by immunoassay at baseline and 30 min after the intravenous ACTH infusion. We used receiver operating characteristics (ROC) curve analysis and matched the parameters to PASO outcomes.

Results

Eighty-one percent of patients had complete, 13% partial, and 6% absent biochemical remission. Complete clinical remission was observed in 28%. For a cut-off of 58.5 pg/mL, stimulated PAC could predict partial/absent biochemical remission with a high sensitivity (95%) and reasonable specificity (74%). Stimulated PAC's area under the curve (AUC) (0.89; confidence interval (CI) 0.82-0.96) was significantly higher than other investigated parameters.

Conclusions

Low postoperative ACTH stimulated PAC was predictive of biochemical remission. If confirmed, this approach could reduce follow-up visits to assess biochemical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismAdrenocortical AdenomaHypertensionHumansAldosteroneAdrenocorticotropic HormoneRetrospective StudiesAdrenalectomy

Stichwörter der Autor:innen

ACTH stimulationPASO criteriaaldosteronealdosterone producing adenomahypertension

Substanzen

AldosteroneAdrenocorticotropic Hormone

Autor:innen und Institutionen

  • Medizinische Klinik und Poliklinik IV, LMU Klinikum, 80336 München, Germany.
  • Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, LMU Klinikum, 80336 München, Germany.
  • Klinik und Poliklinik für Radiologie, LMU Klinikum, 80336 München, Germany.
  • Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitäts-Spital Zürich (USZ) und Universität Zürich (UZH), Raemistrasse 100, CH-8091 Zürich, Switzerland.
  • Hormon- und Stoffwechselzentrum München, Residenzstr. 3, 80333 München, Germany.

ORCID-Profile: Denise Bruedgam, Christian Adolf, Holger Schneider, Martin Bidlingmaier, Felix Beuschlein, Martin Reincke, Daniel A Heinrich

Förderung

  • Else Kröner-Fresenius-Stiftung
  • German Conn's
  • Registry‒Else Kröner Hyperaldosteronism Registry
  • European Research Council under the European Union's
  • Horizon 2020 research and innovation programme
  • Clinical Research Priority Program of the University of Zurich for the CRPP HYRENE
  • Förderung für Forschung und Lehre
  • LMU University Hospital Munich

Zitieren

APA

Bruedgam, D., Adolf, C., Schneider, H., Schwarzlmueller, P., Mueller, L., Handgriff, L., Bidlingmaier, M., Kunz, S., Zimmermann, P., Deniz, S., Williams, T. A., Beuschlein, F., Reincke, M., & Heinrich, D. A. (2023). Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvad159

Vancouver

Bruedgam D, Adolf C, Schneider H, Schwarzlmueller P, Mueller L, Handgriff L, et al. Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism. European Journal of Endocrinology. 2023. doi:10.1093/ejendo/lvad159

BibTeX
@article{Bruedgam2023,
  author = {Bruedgam, Denise and Adolf, Christian and Schneider, Holger and Schwarzlmueller, Paul and Mueller, Lisa and Handgriff, Laura and Bidlingmaier, Martin and Kunz, Sonja and Zimmermann, Petra and Deniz, Sinan and Williams, Tracy Ann and Beuschlein, Felix and Reincke, Martin and Heinrich, Daniel A},
  title = {Postoperative ACTH-stimulated aldosterone predicts biochemical outcome in primary aldosteronism},
  journal = {European Journal of Endocrinology},
  year = {2023},
  doi = {10.1093/ejendo/lvad159}
}
Kostenlos starten →